Wang, Zengguang <br/><br/>
Downregulation of Src enhances the cytotoxic effect of temozolomide             through AKT in glioma.  [electronic resource] 

 -  Oncology reports  Apr 2013 
 - 1395-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1791-2431 
<br/><br/><label>Standard No.: </label>10.3892/or.2013.2240  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apoptosis--drug effects<br/>Brain Neoplasms--drug therapy<br/>Cell Line, Tumor<br/>Dacarbazine--administration & dosage<br/>Down-Regulation<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Glioblastoma--drug therapy<br/>Glioma--drug therapy<br/>Humans<br/>Mice<br/>Oncogene Protein v-akt--antagonists & inhibitors<br/>Signal Transduction--drug effects<br/>Temozolomide<br/>Xenograft Model Antitumor Assays<br/>src-Family Kinases--genetics